These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Amlodipine and vascular hypertrophy. Stepien O, Iouzalen L, Herembert T, Zhu DL, Marche P. Int J Cardiol; 1997 Dec 31; 62 Suppl 2():S79-84. PubMed ID: 9488198 [Abstract] [Full Text] [Related]
3. Calcium antagonists and vascular smooth muscle cell reactivity. Marche P, Stepien O. Z Kardiol; 2000 Dec 31; 89 Suppl 2():140-4. PubMed ID: 10769418 [Abstract] [Full Text] [Related]
4. Dual mechanism of action of amlodipine in human vascular smooth muscle cells. Stepien O, Zhang Y, Zhu D, Marche P. J Hypertens; 2002 Jan 31; 20(1):95-102. PubMed ID: 11791031 [Abstract] [Full Text] [Related]
5. Novel mechanisms of the antiproliferative effects of amlodipine in vascular smooth muscle cells from spontaneously hypertensive rats. Lai YM, Fukuda N, Su JZ, Suzuki R, Ikeda Y, Takagi H, Tahira Y, Kanmatsuse K. Hypertens Res; 2002 Jan 31; 25(1):109-15. PubMed ID: 11924715 [Abstract] [Full Text] [Related]
6. The inhibitory mechanisms of amlodipine in human vascular smooth muscle cell proliferation. Zhang YZ, Gao PJ, Wang XY, Stepien O, Marche P, Zhang ZL, Zhu DL. Hypertens Res; 2000 Jul 31; 23(4):403-6. PubMed ID: 10912781 [Abstract] [Full Text] [Related]
7. Effects of the L- and N-type calcium channel blocker cilnidipine on growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hu WY, Fukuda N, Su JZ, Kanmatsuse K. J Cardiovasc Pharmacol; 2001 Sep 31; 38(3):450-9. PubMed ID: 11486249 [Abstract] [Full Text] [Related]
8. Amlodipine inhibits thapsigargin-sensitive CA(2+) stores in thrombin-stimulated vascular smooth muscle cells. Stepien O, Marche P. Am J Physiol Heart Circ Physiol; 2000 Sep 31; 279(3):H1220-7. PubMed ID: 10993788 [Abstract] [Full Text] [Related]
9. Antiproliferative effects of PCA-4230, a new antithrombotic drug, in vascular smooth muscle cells. del Rio M, Sunkel C, Larcher F, Ortega MP. Br J Pharmacol; 1997 Apr 31; 120(7):1360-6. PubMed ID: 9105713 [Abstract] [Full Text] [Related]
10. Involvement of calcium channels in fibroblast growth factor-induced activation of arterial cells in spontaneously hypertensive rats. Zhu DL, Hérembert T, Caruelle D, Caruelle JP, Marche P. J Cardiovasc Pharmacol; 1994 Mar 31; 23(3):395-400. PubMed ID: 7515982 [Abstract] [Full Text] [Related]
11. Effect of serum withdrawal on the contribution of L-type calcium channels (CaV1.2) to intracellular Ca2+ responses and chemotaxis in cultured human vascular smooth muscle cells. Patel MK, Clunn GF, Lymn JS, Austin O, Hughes AD. Br J Pharmacol; 2005 Jul 31; 145(6):811-7. PubMed ID: 15880143 [Abstract] [Full Text] [Related]
12. Bunazosin hydrochloride inhibits exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats by suppressing the response to growth factors. Hu WY, Fukuda N, Soma M, Izumi Y, Kanmatsuse K. J Cardiovasc Pharmacol; 1998 Dec 31; 32(6):975-82. PubMed ID: 9869504 [Abstract] [Full Text] [Related]
13. Mechanism of action of the inhibitory effect of nifedipine on the growth of cultured aortic cells from spontaneously hypertensive and normotensive rats. Hérembert T, Zhu DL, Marche P. Br J Pharmacol; 1995 Apr 31; 114(8):1703-9. PubMed ID: 7541285 [Abstract] [Full Text] [Related]
14. Control of vascular smooth-muscle cell growth by macrophage-colony-stimulating factor. Herembert T, Gogusev J, Zhu DL, Drueke TB, Marche P. Biochem J; 1997 Jul 01; 325 ( Pt 1)(Pt 1):123-8. PubMed ID: 9224637 [Abstract] [Full Text] [Related]
15. Vascular smooth muscle cell migration, atherosclerosis, and calcium channel blockers. Schachter M. Int J Cardiol; 1997 Dec 31; 62 Suppl 2():S85-90. PubMed ID: 9488199 [Abstract] [Full Text] [Related]
16. [Effects of puerarin on proliferation of vascular smooth muscle cells induced by thrombin]. Xu YZ, Wang NF, Li PZ, Wu X, Ling F, Zhang XW. Zhonghua Yi Xue Za Zhi; 2006 Feb 21; 86(7):476-80. PubMed ID: 16677576 [Abstract] [Full Text] [Related]
17. Effects of BAY 10-6734 (Embusartan), a new angiotensin II type I receptor antagonist, on vascular smooth muscle cell growth. Iouzalen L, Stepien O, Marche P. J Pharmacol Exp Ther; 1999 Apr 21; 289(1):181-7. PubMed ID: 10087002 [Abstract] [Full Text] [Related]
18. L-phenylalanine and smooth muscle cell proliferation from SHR and WKY rats. Gao PJ, Zhu DL, Zhan YM, Stepien O, Marche P, Zhao GS. Sheng Li Xue Bao; 1998 Aug 21; 50(4):401-8. PubMed ID: 11324549 [Abstract] [Full Text] [Related]
19. Inhibitory effect of a novel angiotensin II type 1 receptor antagonist RNH-6270 on growth of vascular smooth muscle cells from spontaneously hypertensive rats: different anti-proliferative effect to angiotensin-converting enzyme inhibitor. Teng J, Fukuda N, Suzuki R, Takagi H, Ikeda Y, Tahira Y, Kanmatsuse K. J Cardiovasc Pharmacol; 2002 Feb 21; 39(2):161-71. PubMed ID: 11791001 [Abstract] [Full Text] [Related]
20. Antiproliferative action of an angiotensin I-converting enzyme inhibitory peptide, Val-Tyr, via an L-type Ca2+ channel inhibition in cultured vascular smooth muscle cells. Toshiro M, Ueno T, Tanaka M, Oka H, Miyamotq T, Osajima K, Matsumoto K. Hypertens Res; 2005 Jun 21; 28(6):545-52. PubMed ID: 16231761 [Abstract] [Full Text] [Related] Page: [Next] [New Search]